Carcinoid tumours.


The use of long-acting and potent somatostatin analogues is a major advance in the management of carcinoid tumours. In addition to providing effective symptom relief in malignant carcinoid syndrome, octreotide can also be used for diagnostic purposes. Despite its expense, octreotide is the current agent of choice for the treatment of this condition while… (More)


Cite this paper

@article{Janmohamed1997CarcinoidT, title={Carcinoid tumours.}, author={Salinah Janmohamed and S. R. Bloom}, journal={Postgraduate medical journal}, year={1997}, volume={73 858}, pages={207-14} }